Synthesis and Anticancer Evaluation of 4-Anilinoquinolinylchalcone Derivatives

Int J Mol Sci. 2023 Mar 23;24(7):6034. doi: 10.3390/ijms24076034.

Abstract

A series of 4-anilinoquinolinylchalcone derivatives were synthesized and evaluated for antiproliferative activities against the growth of human cancer cell lines (Huh-7 and MDA-MB-231) and normal lung cells (MRC-5). The results exhibited low cytotoxicity against human lung cells (MRC-5). Among them, (E)-3-{4-{[4-(benzyloxy)phenyl]amino}quinolin-2-yl}-1-(4-methoxyphenyl) prop-2-en-1-one (4a) was found to have the highest cytotoxicity in breast cancer cells and low cytotoxicity in normal cells. Compound 4a causes ATP depletion and apoptosis of breast cancer MDA-MB-231 cells and triggers reactive oxygen species (ROS)-dependent caspase 3/7 activation. In conclusion, it is worth studying 4-anilinoquinolinylchalcone derivatives further as new potential anticancer agents for the treatment of human cancers.

Keywords: 4-anilinoquinolinylchalcone; apoptosis; cytotoxicity; lapatinib; reactive oxygen species.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Apoptosis
  • Breast Neoplasms* / metabolism
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Molecular Structure
  • Reactive Oxygen Species / pharmacology
  • Structure-Activity Relationship

Substances

  • Reactive Oxygen Species
  • Antineoplastic Agents